Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
CPL Ltd. To Close Buffalo Facility

May 24, 2010
260 employees to be laid off as CPL consolidates operations.  Read More »
Abbott To Acquire Piramal's Healthcare Solutions Business

May 21, 2010
Abbott has entered a definitive agreement with Piramal Healthcare Ltd. to acquire Piramal's Healthcare Solutions business (Domestic Formulations), a leader in the Indian branded generics market, for $2.1 billion, plus $400 million annually for the next fo  Read More »
Ablynx, Pfizer Extend TNF-alpha Pact

May 21, 2010
Ablynx and Pfizer have extended their research collaboration and license agreement to discover and develop Nanobody-based therapeutics against tumor necrosis factor alpha (TNF-alpha), for another year.  Read More »
Ligand Acquires Interest in AZ Asthma Program

May 21, 2010
Ligand Pharmaceuticals has purchased certain intellectual property and interests in future milestones and royalties for MEDI-528, an IL-9 antibody program under development by MedImmune, an AstraZeneca subsidiary.  Read More »
Eisai Opens Parenteral Facility in NC

May 20, 2010
Eisai, Inc. has opened its newly constructed parenteral facility in Research Triangle Park (RTP), NC.   Read More »
Pharma Spray Drying Opens New Facility

May 20, 2010
Pharma Spray Drying, Inc. (PSD) has opened its new R&D facility in Norwood, NJ.   Read More »
Quintiles Acquires Nycomed Team

May 20, 2010
Quintiles and Nycomed have entered into an agreement under which Nycomed has transferred a UK-based Healthcare Solutions Team to Quintiles.  Read More »
Vetter Wins SAP Quality Award

May 20, 2010
Vetter has won the silver SAP Quality Award for Europe, the Middle East and Africa (EMEA) for its company-wide implementation of the “mySAP ERP” planning software.  Read More »
Galapagos Begins Phase I Trial for Cachexia Drug

May 20, 2010
Galapagos NV has initiated a Phase I trial for GLPG0492, its candidate drug for cachexia (loss of weight and muscle mass) and potentially other indications, such as Duchenne muscular dystrophy.  Read More »
Roche, Biogen Discontinue Ocrelizumab Program in RA

May 19, 2010
Roche and Biogen Idec are discontinuing development of ocrelizumab in rheumatoid arthritis (RA) following analysis of the safety efficacy results.  Read More »
Chiltern Expands in Asia Pacific

May 19, 2010
Chiltern has established two new offices and launched operations in Australia and Singapore, which will serve as the hub for its operations in Southeast Asia.  Read More »
Millipore Expands Analytical Services in Europe

May 19, 2010
Millipore Corp. has moved its European BioPharma Services unit to new, expanded facilities located in Milton Park, near Didcot in Oxfordshire, England.  Read More »
Evotec Earns Boehringer Pain Milestone

May 19, 2010
Evotec AG has advanced a compound in its strategic alliance with Boehringer Ingelheim into Phase I clinical studies.  Read More »
Quintiles, Kaiser Permanente Enter Drug Development Alliance

May 19, 2010
Quintiles and Kaiser Permanente’s Southern California Permanente Medical Group (SCPMG) have entered an agreement aimed at accelerating the development of new and more effective medicines.  Read More »
Pfizer Restructures Manufacturing Network

May 18, 2010
Pfizer Global Manufacturing is restructuring its worldwide plant network in an effort to align its manufacturing and supply organization following the acquisition of Wyeth.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: